Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133
Get the latest updates from ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133 directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 5 days ago
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
6 days ago
Conditions: Obesity Interventions: Drug: Semaglutide Sponsors: Novo Nordisk A/S Enrolling by invitation
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
6 days ago
Conditions: Atherosclerosis Cardiovascular Disease; Chronic Kidney Disease Interventions: Drug: Orforglipron; Drug: Placebo...
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
6 days ago
Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease Interventions: Drug: Tirzepatide; Drug: Retatrutide; Drug...
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
6 days ago
Conditions: Osteoarthritis Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and Company...
2024 Tirzepatide-Bariatric Surgery
6 days ago
Conditions: Obesity and Obesity-related Medical Conditions; Bariatric Surgery Interventions: Drug: tirzepatide; Behavioral...
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
6 days ago
Conditions: Obesity; Overweight Interventions: Drug: Retatrutide Sponsors: Eli Lilly and Company Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
6 days ago
Conditions: Psoriasis; Overweight or Obesity Interventions: Drug: Tirzepatide Sponsors: Eli Lilly and...
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
6 days ago
Conditions: Peripheral Arterial Disease Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly...
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
6 days ago
Conditions: Obesity; Overweight Interventions: Drug: LY3305677; Drug: LY3841136; Drug: Tirzepatide; Drug: LY3549492...
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
6 days ago
Conditions: Severe Mental Illness; Depression / Major Depressive Disorder; Bipolar Disorder (BD)...
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
6 days ago
Conditions: Obesity; Diabetes Mellitus, Type 2 Interventions: Drug: Tirzepatide (LIPOLESS de Laboratorio...
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
6 days ago
Conditions: Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia; FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma...